Study yields positive results for breast cancer imaging agent

03/17/2013 | Yahoo

NuView Life Sciences' PET imaging agent for breast cancer, NLS-VPAC1, was able to detect 100% of malignant lesions and sentinel lymph nodes, according to findings presented at an international conference. Because of the agent's rapid uptake in tumors, the company is also investigating its use when labeled with the isotope gallium-68, which can be manufactured at local radiopharmacies. The agent may allow for noninvasive diagnosis of malignancies in the breast and other tissues, a researcher said.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN